Awaiting the outcome of the Patient Capital Review with an eagerness that borders on, well, impatience, Ian Battersby wonders how financial advisers will be expected to embrace whatever new rules emerge
The results of the Patient Capital Review are eagerly anticipated by tax-advantaged product providers, advisers and investors alike but, at the present time, there is very little clarity about what might...
Safe finances, safe data, safe clients
Owner Gary Whyte to retire
To build 'sustainable support system'
Soft launch this week
'Providers should stump up data'